LAS VEGAS, NV--(Marketwired - Feb 26, 2015) - Alkame Holdings, Inc. (
"Alkame Water and I make a wonderful team. I'm proud to be a brand ambassador and I look forward to growing a strong partnership together, with Alkame Water keeping me hydrated both on and off the track," stated 22 year old Brycen Spratling. A recent University of Pittsburgh graduate, Brycen is a 10 time collegiate All American who holds the NCAA 500 meter record, who will now look to qualify for the World Championships this summer, and the 2016 Olympics in Rio.
"Brycen is another fine example of an up-and-coming athlete that Alkame likes to team up with, and be a part of their rise to greatness," stated Robert Eakle, Alkame CEO. "We are extremely proud of Brycen's world record and to have Brycen as a part of Team Alkame, representing our growing brand in the Track and Field Community around the world."
About Alkame Holdings, Inc. (ALKM) Alkame Holdings, Inc. is a publicly traded health and technology holding company with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiary, Alkame Water, Inc., markets and distributes micro-clustered, alkaline, antioxidant and oxygenated bottled water utilizing an exclusive patented formula and technology. Alkame uses this patented technology to create water with several unique properties which allow the body to absorb and utilize it more efficiently and help to achieve an optimal pH balance. This patented technology also increases the available oxygen content and absorbability which equates to more fuel for improved metabolic efficiency, boosted immune system, and improved cardio respiratory function.
For more information visit: www.alkameholdingsinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.